A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

Clinical trial NCT07137338 · RECRUITING

Trial details

NCT number: NCT07137338
Sponsor: Rocket Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Dilated Cardiomyopathy (DCM)

Start date: 2026-06-01
Primary completion: 2029-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.